Ipsen to Host an Investor Day to Highlight Its Innovative R&D Pipeline and Provide Financial Outlook for 2022
5 new chemical entities advancing in pipeline 9 significant regulatory submissions planned from 2019 to 2022 2022 financial outlook of…
Pharmaceuticals, Biotechnology and Life Sciences
5 new chemical entities advancing in pipeline 9 significant regulatory submissions planned from 2019 to 2022 2022 financial outlook of…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…
IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of this life sciences segment…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS) (the “Company”), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products,…
This partnership will also include sister platform The American Journal of Managed Care® CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AJMC?src=hash" target="_blank"gt;#AJMClt;/agt;–Targeted Oncology™, a…
This partnership will also include sister platform The American Journal of Managed Care® CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AJMC?src=hash" target="_blank"gt;#AJMClt;/agt;–Targeted Oncology™, a…
DENVER–(BUSINESS WIRE)–ClinOne is pleased to announce that Dr. Elizabeth Esterl joins ClinOne as our VP of Operations and Research. Dr.…
€9.1 Million in Cash and Cash Equivalents as of March 31, 2019 €20 million revolving credit facility secured with Natixis…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/HealthcareSupplyChain?src=hash" target="_blank"gt;#HealthcareSupplyChainlt;/agt;–SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article…
DUBLIN–(BUSINESS WIRE)–The “Global Addison’s Disease Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The Addison’s disease therapeutics market…